Allstate Corporation’s Royalty Pharma RPRX Stock Holding History

Allstate Corporation’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.26M	Buy	58,143 +745	+1%	+$38.8K	0.03%	322
2026 Q1	$2.75M	Buy	57,398 +29,025	+102%	+$1.27M	0.03%	401
2025 Q4	$1.1M	Buy	28,373 +15,479	+120%	+$590K	0.02%	509
2025 Q3	$455K	Buy	+12,894	New	+$467K	0.01%	535
2025 Q2	–	Sell	-17,821	Closed	-$555K	–	493
2025 Q1	$555K	Buy	17,821 +6,103	+52%	+$193K	0.02%	482
2024 Q4	$299K	Buy	+11,718	New	+$311K	0.01%	582
2023 Q1	–	Sell	-13,238	Closed	-$523K	–	492
2022 Q4	$523K	Buy	13,238 +132	+1%	+$5.51K	0.02%	487
2022 Q3	$527K	Hold	13,106	–	–	0.02%	483
2022 Q2	$551K	Buy	13,106 +4,083	+45%	+$167K	0.02%	485
2022 Q1	$352K	Buy	+9,023	New	+$354K	0.01%	548

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allstate Corporation's RPRX Position: Q2 2026 in Review

Allstate Corporation increased its Royalty Pharma (RPRX) stake by 1.3% in Q2 2026, buying an estimated $38.8K and bringing the position to 58,143 shares worth $3.26M. The position accounts for 0.03% of the portfolio, ranked #322.

Allstate Corporation first reported a position in RPRX in Q1 2022 and has held it in 10 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Allstate Corporation held 58,143 shares of Royalty Pharma worth $3.26M as of Q2 2026.
Allstate Corporation bought 745 Royalty Pharma shares in Q2 2026, an estimated $38.8K.
Royalty Pharma made up 0.03% of Allstate Corporation's portfolio in Q2 2026, its #322 holding.
Allstate Corporation first reported a position in Royalty Pharma in Q1 2022 and has held it in 10 quarters since.
646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.